BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10

• Press Releases

  Real-World Evidence Supports Clinical Effectiveness of neffy® (epinephrine nasal spray) in Patients Experiencing Anaphylaxis

  September 9, 2025

   · 

  12 min read
• Press Releases

  NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults

  September 9, 2025

   · 

  7 min read
• Press Releases

  Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment

  September 9, 2025

   · 

  4 min read
• Press Releases

  Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting

  September 9, 2025

   · 

  6 min read
• Press Releases

  OncoC4 to Present Global Pivotal Phase 3 Trial Design for Next-Generation CTLA-4 Antibody Gotistobart Monotherapy Being Co-Developed with BioNTech in NSCLC at the IASLC 2025 World Conference on Lung Cancer

  September 9, 2025

   · 

  4 min read
• Press Releases

  Sionna Therapeutics Appoints Caroline Stark Beer as Chief Business Officer

  September 9, 2025

   · 

  5 min read
• Press Releases

  UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 8, 2025

  September 9, 2025

   · 

  2 min read
• Press Releases

  Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025

  September 9, 2025

   · 

  2 min read
• Press Releases

  Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors

  September 9, 2025

   · 

  6 min read
• Press Releases

  Vaxart Announces Adjournment of Special Meeting of Stockholders

  September 9, 2025

   · 

  6 min read